After Patent Expires, Pfizer Staying with Lipitor


Published On: November 3rd, 2011

Dow Jones Newswires reporter Peter Loftus has details of Pfizer’s decision to aggressively market branded cholesterol-lowering drug Lipitor after the patent expires at the end of November. AP Photo/Mel Evans, File

View original here:
After Patent Expires, Pfizer Staying with Lipitor/a>

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

Stop Panic Attacks
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

try-now

YouTube Video



Loading...


Did You Know Did you know:


Racial and ethnic minorities are more likely to live in heavily polluted neighborhoods and work in high-risk occupations with lower air quality. Disparities in living and working conditions play a critical role in the incidence and burden of asthma in these populations

Related Posts

  • Four months after Lipitor goes off patent, Ranbaxy is the leading seller
    Attention Lipitor patients: there are good odds now that your pills were sold by generic drug maker Ranbaxy Laboratories, not the cholesterol fighting drug’s longtime maker, Pfizer. Ranbaxy is now selling more pills than Pfizer, according to Wolters Kluwer Pharma Solutions. That makes Ranbaxy the leading seller of the top-selling drug of all time. ..
  • A.M. Vitals: Pfizer CEO Ian Read Says There’s Life After Lipitor
    Looking Past the Cliff: In an interview with the WSJ , new Pfizer CEO Ian Read says that the company won’t lose all of the roughly $11 billion in sales generated by Lipitor when the anti-cholesterol drug loses patent protection later this year. ..
  • A.M. Vitals: Pfizer Parts With Lipitor
    Also: The FDA warns about bone-strengthening drugs; Washington will pay primary-care doctors more; and a patients’ pain group folds hours after senators announce a probe. ..
  • A.M. Vitals: Express Scripts Will Make Changes to Lipitor Coverage
    Lipitor Benefit Changes: Pharmacy-benefit manager Express Scripts will move brand-name Lipitor to the third tier of its national drug formulary from the second tier as of Feb. 1, increasing co-pays for some patients and emphasizing Pfizer’s challenge of holding on to sales of the drug, the WSJ reports . The generic versions of Lipitor are..
  • Lipitor to Sell at Generic Prices as Patent Ends
    Pfizer will seek to hold onto sales of its cholesterol fighter Lipitor, even after it loses U.S. patent protection at the end of this month, by selling the pills at generic prices directly to patients. ..
  • Pfizer, Spanning the Globe to Defend Lipitor Patents
    Emerging markets may be essential to the growth of the global drug industry, but that doesn’t mean growth comes easily in the developing world. ..
Leave a comment
Comments are closed.
« A.M. Vitals: Prescription Painkillers Kill More People Than Heroin and Cocaine Painkiller Deaths Nearly Quadruple in a Decade »